The Clorox Company $CLX Shares Bought by Prudential Financial Inc.

Prudential Financial Inc. increased its position in The Clorox Company (NYSE:CLX) by 12.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 74,043 shares of the company’s stock after acquiring an additional 8,213 shares during the period. Prudential Financial Inc. owned approximately 0.06% of Clorox worth $8,890,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Vanguard Group Inc. grew its holdings in Clorox by 1.7% in the second quarter. Vanguard Group Inc. now owns 15,845,496 shares of the company’s stock valued at $1,902,569,000 after purchasing an additional 272,420 shares during the last quarter. Northern Trust Corp raised its stake in shares of Clorox by 2.3% during the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after buying an additional 34,655 shares during the last quarter. Invesco Ltd. boosted its position in shares of Clorox by 7.4% in the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock worth $200,512,000 after buying an additional 94,371 shares in the last quarter. ProShare Advisors LLC grew its stake in Clorox by 7.0% in the 2nd quarter. ProShare Advisors LLC now owns 1,160,881 shares of the company’s stock valued at $139,387,000 after acquiring an additional 75,514 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Clorox by 3.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock valued at $170,406,000 after acquiring an additional 41,485 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CLX. Barclays reduced their price target on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a report on Tuesday, November 4th. Wells Fargo & Company reduced their target price on Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft lowered their target price on Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a report on Tuesday, November 4th. Morgan Stanley cut their price target on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $152.00 price objective on shares of Clorox in a research note on Tuesday, November 4th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, Clorox has a consensus rating of “Reduce” and an average price target of $125.69.

Insider Activity at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Pierre R. Breber acquired 4,000 shares of the stock in a transaction dated Friday, November 21st. The shares were bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX stock opened at $107.32 on Friday. The Clorox Company has a 52-week low of $98.20 and a 52-week high of $171.37. The stock’s fifty day simple moving average is $113.61 and its 200-day simple moving average is $121.36. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The stock has a market capitalization of $13.09 billion, a price-to-earnings ratio of 16.46, a price-to-earnings-growth ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same period in the prior year, the firm posted $1.86 earnings per share. The business’s quarterly revenue was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities research analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.6%. The ex-dividend date is Wednesday, January 28th. Clorox’s payout ratio is presently 77.86%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.